Cargando…

Efficacy and Safety of Capecitabine and Oxaliplatin (CapOX) as an Adjuvant Therapy in Japanese for Stage II/III Colon Cancer in a Group at High Risk of Recurrence in Retrospective Study

A number of large-scale clinical trials have demonstrated that using a combination of oxaliplatin and fluoropyrimidines as an adjuvant chemotherapy for stage II/III colon cancer improved the prognosis. However, there has only been experience in Japanese patients with using CapOX therapy, in which ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Osawa, Hiroshi, Handa, Naoko, Minakata, Kunihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842523/
https://www.ncbi.nlm.nih.gov/pubmed/26629945
http://dx.doi.org/10.3727/096504015X14410238486522